Towards a cancer mission in Horizon Europe: recommendations

A comprehensive translational cancer research approach focused on personalized and precision medicine, and covering the entire cancer research–care–prevention continuum has the potential to achieve in 2030 a 10‐year cancer‐specific survival for 75% of patients diagnosed in European Union (EU) member...

Descripción completa

Detalles Bibliográficos
Autores principales: Berns, Anton, Ringborg, Ulrik, Celis, Julio E., Heitor, Manuel, Aaronson, Neil K., Abou‐Zeid, Nancy, Adami, Hans‐Olov, Apostolidis, Kathi, Baumann, Michael, Bardelli, Alberto, Bernards, René, Brandberg, Yvonne, Caldas, Carlos, Calvo, Fabien, Dive, Caroline, Eggert, Angelika, Eggermont, Alexander, Espina, Carolina, Falkenburg, Frederik, Foucaud, Jérôme, Hanahan, Douglas, Helbig, Ulrike, Jönsson, Bengt, Kalager, Mette, Karjalainen, Sakari, Kásler, Miklós, Kearns, Pamela, Kärre, Klas, Lacombe, Denis, de Lorenzo, Francesco, Meunier, Françoise, Nettekoven, Gerd, Oberst, Simon, Nagy, Péter, Philip, Thierry, Price, Richard, Schüz, Joachim, Solary, Eric, Strang, Peter, Tabernero, Josep, Voest, Emile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Policy Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400777/
https://www.ncbi.nlm.nih.gov/pubmed/32749074
http://dx.doi.org/10.1002/1878-0261.12763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400777/
https://www.ncbi.nlm.nih.gov/pubmed/32749074
http://dx.doi.org/10.1002/1878-0261.12763

Ejemplares similares